Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

PURPOSE: Several options are available for the treatment of hypertension; however, many treated patients are still not below blood pressure (BP) target. Eplerenone, a selective mineralocorticoid receptor antagonist, is an approved treatment option for the management of patients with hypertension in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernet, Mireille, Beckerman, Bruce, Abreu, Paula, Lins, Katharina, Vincent, John, Burgess, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157540/
https://www.ncbi.nlm.nih.gov/pubmed/30275698
http://dx.doi.org/10.2147/VHRM.S170141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157540/
https://www.ncbi.nlm.nih.gov/pubmed/30275698
http://dx.doi.org/10.2147/VHRM.S170141

Ejemplares similares